Literature DB >> 2178314

Brain tumours under the age of three. The price of survival. A retrospective study of 20 long-term survivors.

E Suc1, C Kalifa, R Brauner, J L Habrand, M J Terrier-Lacombe, G Vassal, J Lemerle.   

Abstract

Between 1975 and 1989, 98 children with brain tumours under the age of three at time of diagnosis were entered into a retrospective study. Twenty of them are alive and free of tumour more than five years after treatment and were evaluated in this study. Thirteen tumour localizations were infratentorial and 7 were supratentorial. A histological examination was performed in 15 patients: 5 ependymomas, 6 medulloblastomas and 4 astrocytomas were identified. Fifteen patients underwent surgical removal of tumour, all but one received radiotherapy and 8 were given chemotherapy. Only two children have not late effects. Analysis of long-term sequelae in survivors showed central endocrinopathies in 14 (70%), a neurological handicap in 13 (65%) and impaired cognitive functions in 17 (85%). Irradiation was clearly responsible for mental sequelae in 7 patients and endocrinopathies in 6 patients. The other possible causes are tumour injury, hydrocephalus or surgery. The risks incurred with radiotherapy and advances in infant brain tumour therapy are discussed.

Entities:  

Mesh:

Year:  1990        PMID: 2178314     DOI: 10.1007/BF01809448

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  30 in total

1.  Quality of long-term survival following irradiation for intracranial tumors in children under the age of two.

Authors:  J J Spunberg; C H Chang; M Goldman; E Auricchio; J J Bell
Journal:  Int J Radiat Oncol Biol Phys       Date:  1981-06       Impact factor: 7.038

2.  Follow-up of children with brain tumors.

Authors:  F P Li; K R Winston; K Gimbrere
Journal:  Cancer       Date:  1984-07-01       Impact factor: 6.860

3.  Brain tumors during the first twenty-four months of life.

Authors:  T Tomita; D G McLone
Journal:  Neurosurgery       Date:  1985-12       Impact factor: 4.654

4.  Hypothalamic, pituitary and thyroid dysfunction after radiotherapy to the head and neck.

Authors:  N A Samaan; R Vieto; P N Schultz; M Maor; R T Meoz; V A Sampiere; A Cangir; H L Ried; R H Jesse
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-11       Impact factor: 7.038

5.  Long-term effects of cranial irradiation on endocrine function in children with brain tumors. A prospective study.

Authors:  P K Duffner; M E Cohen; M L Voorhess; M H MacGillivray; M L Brecher; A Panahon; B B Gilani
Journal:  Cancer       Date:  1985-11-01       Impact factor: 6.860

Review 6.  Long-term sequelae of cancer treatment on the central nervous system in childhood.

Authors:  R J Packer; A T Meadows; L B Rorke; J L Goldwein; G D'Angio
Journal:  Med Pediatr Oncol       Date:  1987

7.  MOPP regimen as primary chemotherapy for brain tumors in infants.

Authors:  J van Eys; A Cangir; D Coody; B Smith
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

8.  Late effects of radiotherapy on patients with cerebellar medulloblastoma.

Authors:  C L Silverman; H Palkes; B Talent; E Kovnar; J W Clouse; P R Thomas
Journal:  Cancer       Date:  1984-09-01       Impact factor: 6.860

9.  Cognitive function in long survivors of childhood acute lymphoblastic leukemia.

Authors:  A E Schlieper; D W Esseltine; E Tarshis
Journal:  Pediatr Hematol Oncol       Date:  1989       Impact factor: 1.969

10.  Effects of central-nervous-system irradiation on neuropsychologic functioning of children with acute lymphocytic leukemia.

Authors:  S S Soni; G W Marten; S E Pitner; D A Duenas; M Powazek
Journal:  N Engl J Med       Date:  1975-07-17       Impact factor: 91.245

View more
  9 in total

1.  Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma?

Authors:  S Dupuis-Girod; O Hartmann; E Benhamou; F Doz; F Mechinaud; E Bouffet; C Coze; C Kalifa
Journal:  J Neurooncol       Date:  1996-01       Impact factor: 4.130

2.  Progressive disease in children with medulloblastoma/PNET during preradiation chemotherapy.

Authors:  A Tornesello; S Mastrangelo; D Piciacchia; V Bembo; C Colosimo; C Di Rocco; R Mastrangelo
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

Review 3.  The therapy of infantile malignant brain tumors: current status?

Authors:  Chantal Kalifa; Jacques Grill
Journal:  J Neurooncol       Date:  2005-12       Impact factor: 4.130

4.  Characterization, treatment, and outcome of intracranial neoplasms in the first 120 days of life.

Authors:  Ibrahim Qaddoumi; Steven S Carey; Heather Conklin; Jesse Jenkins; Noah Sabin; Frederick Boop; Atmaram Pai-Panandiker; Justin Baker; Karen Wright; Alberto Broniscer; Amar Gajjar
Journal:  J Child Neurol       Date:  2011-04-30       Impact factor: 1.987

5.  The effect of NACHRI children's hospital designation on outcome in pediatric malignant brain tumors.

Authors:  Daniel A Donoho; Timothy Wen; Jonathan Liu; Hosniya Zarabi; Eisha Christian; Steven Cen; Gabriel Zada; J Gordon McComb; Mark D Krieger; William J Mack; Frank J Attenello
Journal:  J Neurosurg Pediatr       Date:  2017-06-02       Impact factor: 2.375

6.  Survival following intensive chemotherapy with bone marrow reconstitution for children with recurrent intracranial ependymoma--a report of the Children's Cancer Group.

Authors:  W P Mason; S Goldman; A J Yates; J Boyett; H Li; J L Finlay
Journal:  J Neurooncol       Date:  1998-04       Impact factor: 4.130

7.  Intracranial tumours in the first year of life. A report on 51 cases.

Authors:  C Di Rocco; A Ceddia; A Iannelli
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

Review 8.  Childhood ependymoma: a systematic review of treatment options and strategies.

Authors:  Jacques Grill; Chastagner Pascal; Kalifa Chantal
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

9.  Desmoplastic nodular medulloblastoma in young children: a management dilemma.

Authors:  Mohamed S AbdelBaki; Daniel R Boué; Jonathan L Finlay; Mark W Kieran
Journal:  Neuro Oncol       Date:  2018-07-05       Impact factor: 12.300

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.